PsiF DNA
SI Joint Stabilization
PsiF DNA combines a familiar posterior approach with Omnia's PsiFGuard technology to deliver consistent, confident SI joint stabilization. Minimally invasive and efficiently designed to address SI joint dysfunction.
PsiF DNA: Built Different
An Overlooked Source of Chronic Pain
Sacroiliac joint dysfunction is far more prevalent than many realize, yet it often goes undiagnosed or misattributed to other conditions.
The numbers tell the story:
Up to 75% of patients with lower back pain are actually suffering from SI joint dysfunction
Up to 25% of lumbar fusion patients develop significant SI joint degeneration within 5 years
Like all orthopedic joints, the SI joint can deteriorate and become a source of chronic pain, especially following lumbar fusion. This is why physicians have been treating SI joint dysfunction since the early 1900s, and why targeted stabilization remains essential today.
The PsiF DNA Advantage
Familiar Posterior Approach
PsiF DNA uses a posterior approach that surgeons know and trust, enhanced by Omnia's PsiFGuard technology to ensure consistency and confidence during implant placement.
Minimally Invasive Design
Thoughtfully engineered with intuitive instrumentation, PsiF DNA offers a streamlined solution that supports outpatient procedures and reduces hospital stay times.
Efficient Workflow Integration
The straightforward design allows you to focus on technique rather than equipment, with a system built for time efficiency and procedural simplicity without added complexity.
Access our PsiF Coding Guides
Share some quick information and gain access to our 2026 PsiF Coding Guides and an exclusive webinar with our CPC professional.
